Joshua Pinto - 17 Feb 2026 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Role
President
Signature
/s/ Michael Milligan, as Attorney-in-Fact for Joshua Pinto
Issuer symbol
NMRA
Transactions as of
17 Feb 2026
Net transactions value
-$21,093
Form type
4
Filing time
19 Feb 2026, 17:06:16 UTC
Previous filing
09 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pinto Joshua President C/O NEUMORA THERAPEUTICS, INC., 260 ARSENAL WAY, SUITE 1, WATERTOWN /s/ Michael Milligan, as Attorney-in-Fact for Joshua Pinto 19 Feb 2026 0001992595

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMRA Common Stock Sale $21,093 -5,967 -9.4% $3.54 57,783 17 Feb 2026 Direct F1
holding NMRA Common Stock 152,167 17 Feb 2026 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
F2 Shares held by Maple DE Holdings LLC.